CytoGenix, Inc. Receives Coverage and Rating by Independent Research Firm J.M. Dutton and Associates LLC.Business Editors HOUSTON--(BUSINESS WIRE)--Aug. 1, 2002 CytoGenix, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CYGX) J.M. Dutton & Associates has initiated research coverage of CytoGenix, Inc. with a Speculative Buy rating and a 12-month $1.00 price target (recent price $.20). The 16-page report by J.M. Dutton senior analyst Sherry Grisewood, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , is available at www.jmdutton.com as well as from Zacks, First Call, Multex, and other leading financial portals. CytoGenix, Inc. is also featured in J.M. Dutton's Small Cap Manager as one of "...Six Micro Caps Worth Watching". The Small Cap Manager Report is distributed to 750 Small Cap fund managers as well as 1.5 million individual investors in association with Executech Financial Advisors, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control . In the report, CytoGenix is referred to as one of "...Six Micro Caps Worth Watching". Excerpt ex·cerpt n. A passage or segment taken from a longer work, such as a literary or musical composition, a document, or a film. tr.v. ex·cerpt·ed, ex·cerpt·ing, ex·cerpts 1. From Ms. Grisewood, CFA of J.M. Dutton on CytoGenix: "CytoGenix (BB: CYGX). CytoGenix has patented core technology exploiting the manipulation of RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic to produce gene-based therapeutics based on gene-silencing (blocking), RNA (ribonucleic acid Ribonucleic acid (RNA) One of the two major classes of nucleic acid, mainly involved in translating into proteins the genetic information that is carried in deoxyribonucleic acid (DNA). ) interference, and other gene modification applications. The story is largely unknown among researchers and investors alike. However, our scan of patent applications in this area clearly indicates the cusp of a tidal wave tidal wave, term properly applied to the crest of a tide as it moves around the earth. The wavelike upstream rush of water caused by the incoming tide in some locations is known as a tidal bore. of research and development activity in a variety of RNA directed therapeutic strategies. Speculative Buy." CytoGenix, Inc., is a Houston-based biopharmaceutical company that develops and markets innovative products and services based on its proprietary single stranded DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. (ssDNA) expression technology. CytoGenix currently has one issued US patent and 36 international or US pending patent applications claiming methods and materials in connection with this platform technology. About Dutton & Associates Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 18 senior analysts, primarily CFAs, have expertise in many industries including healthcare, technology, finance, banking, mining, gaming, and energy. Dutton & Associates provides economically bias-free, continuing analyst coverage of enrolled companies, and its institutional-quality research, estimates, and recommendations are carried in all the major databases serving institutions and online investors. The cost of enrollment in the Dutton & Associates one-year continuing research program is US $25,000 prepaid before commencement of its research activities. Dutton & Associates does not accept payment of any of its fees in company stock. Its principals and analysts are prohibited from owning or trading in securities of covered companies. Please read full disclosures at www.jmdutton.com before investing. SAFE HARBOR Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. : Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com or call CytoGenix Business Development Contact: Maury M. Fogle (281) 988-6118 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion